Advanced Materials,
Journal Year:
2017,
Volume and Issue:
29(33)
Published: July 3, 2017
Photodynamic
therapy
(PDT),
which
relies
on
photosensitizers
(PS)
and
light
to
generate
reactive
oxygen
species
kill
cancer
cells
or
bacteria,
has
attracted
much
attention
in
recent
years.
PSs
with
both
bright
emission
efficient
singlet
generation
have
also
been
used
for
image-guided
PDT.
However,
simultaneously
achieving
effective
1
O2
generation,
long
wavelength
absorption,
stable
near-infrared
(NIR)
low
dark
toxicity
a
single
PS
remains
challenging.
In
addition,
it
is
well
known
that
when
traditional
are
made
into
nanoparticles,
they
encounter
quenched
fluorescence
reduced
production.
this
contribution,
these
challenging
issues
successfully
addressed
through
designing
the
first
photostable
photosensitizer
aggregation-induced
NIR
very
aggregate
state.
The
yielded
nanoparticles
show
centered
at
820
nm,
excellent
photostability,
good
biocompatibility,
negligible
vivo
toxicity.
Both
vitro
experiments
prove
candidates
photodynamic
anticancer
therapy.
ACS Nano,
Journal Year:
2017,
Volume and Issue:
11(5), P. 4463 - 4474
Published: March 31, 2017
While
immunotherapy
has
become
a
highly
promising
paradigm
for
cancer
treatment
in
recent
years,
it
long
been
recognized
that
photodynamic
therapy
(PDT)
the
ability
to
trigger
antitumor
immune
responses.
However,
conventional
PDT
triggered
by
visible
light
limited
penetration
depth,
and
its
generated
responses
may
not
be
robust
enough
eliminate
tumors.
Herein,
upconversion
nanoparticles
(UCNPs)
are
simultaneously
loaded
with
chlorin
e6
(Ce6),
photosensitizer,
imiquimod
(R837),
Toll-like-receptor-7
agonist.
The
obtained
multitasking
UCNP-Ce6-R837
under
near-infrared
(NIR)
irradiation
enhanced
tissue
depth
would
enable
effective
destruction
of
tumors
generate
pool
tumor-associated
antigens,
which
presence
those
R837-containing
as
adjuvant
able
promote
strong
More
significantly,
combination
cytotoxic
T-lymphocyte-associated
protein
4
(CTLA-4)
checkpoint
blockade
only
shows
excellent
efficacy
eliminating
exposed
NIR
laser
but
also
results
immunities
inhibit
growth
distant
left
behind
after
treatment.
Furthermore,
such
strategy
long-term
memory
function
protect
treated
mice
from
tumor
cell
rechallenge.
This
work
presents
an
immune-stimulating
UCNP-based
CTLA-4
effectively
destroy
primary
exposure,
can
hardly
reached
light,
prevent
reoccurrence
via
effect.
Angewandte Chemie International Edition,
Journal Year:
2020,
Volume and Issue:
59(25), P. 9868 - 9886
Published: March 4, 2020
Abstract
The
concept
of
aggregation‐induced
emission
(AIE)
has
opened
new
opportunities
in
many
research
fields.
Motivated
by
the
unique
feature
AIE
fluorogens
(AIEgens),
during
past
decade,
molecular
probes
and
nanoparticle
(NP)
have
been
developed
for
sensing,
imaging
theranostic
applications
with
excellent
performance
outperforming
conventional
fluorescent
probes.
This
Review
summarizes
latest
advancement
NP
their
emerging
biomedical
applications.
Special
focus
is
to
reveal
how
are
evolved
development
multifunctional
AIEgens,
strategies
overcome
limitations
traditional
more
translational
via
fluorescence
imaging,
photoacoustic
image‐guided
photodynamic/photothermal
therapy.
outlook
discusses
challenges
future
AIEgens
advance
field.
ACS Nano,
Journal Year:
2019,
Volume and Issue:
13(4), P. 4267 - 4277
Published: March 22, 2019
The
integration
of
reactive
oxygen
species
(ROS)-involved
photodynamic
therapy
(PDT)
and
chemodynamic
(CDT)
holds
great
promise
for
enhanced
anticancer
effects.
Herein,
we
report
biodegradable
cancer
cell
membrane-coated
mesoporous
copper/manganese
silicate
nanospheres
(mCMSNs)
with
homotypic
targeting
ability
to
the
lines
ROS
generation
through
singlet
(1O2)
production
glutathione
(GSH)-activated
Fenton
reaction,
showing
excellent
CDT/PDT
synergistic
therapeutic
We
demonstrate
that
mCMSNs
are
able
relieve
tumor
hypoxia
microenvironment
by
catalytic
decomposition
endogenous
H2O2
O2
further
react
produce
toxic
1O2
a
635
nm
laser
irradiation.
GSH-triggered
biodegradation
can
simultaneously
generate
Fenton-like
Cu+
Mn2+
ions
deplete
GSH
efficient
hydroxyl
radical
(•OH)
production.
specific
recognition
cells
were
also
revealed.
Notably,
relieving
depletion
disrupts
(TME)
cellular
antioxidant
defense
system,
achieving
exceptional
cancer-targeting
effects
in
vitro
vivo.
growth
was
significantly
inhibited.
Moreover,
released
act
as
an
advanced
contrast
agent
magnetic
resonance
imaging
(MRI).
Thus,
together
photosensitizers,
provider
MRI
along
modulating
TME
allow
realize
MRI-monitored
therapy.
It
provides
paradigm
rationally
design
TME-responsive
ROS-involved
strategies
based
on
single
polymetallic
nanomaterial
Chemical Society Reviews,
Journal Year:
2020,
Volume and Issue:
49(22), P. 8179 - 8234
Published: Jan. 1, 2020
Phototheranostics
represents
a
promising
direction
for
modern
precision
medicine,
which
has
recently
attracted
great
research
interest
from
multidisciplinary
areas.
Organic
optical
agents
including
small
molecular
fluorophores,
semiconducting/conjugated
polymers,
aggregation-induced
emission
luminogens,
etc.
with
tuneable
photophysical
properties,
high
biosafety
and
biocompatibility,
facile
processability
ease
of
functionalization
have
delivered
encouraging
performance
in
disease
phototheranostics.
This
review
summarizes
the
recent
progress
organic
phototheranostic
an
emphasis
on
main
strategies
to
manipulate
three
excitation
energy
dissipation
pathways,
namely,
radiative
decay,
thermal
deactivation,
intersystem
crossing,
assistance
Jablonski
diagram,
particularly
showcases
how
diagram
been
guiding
design
molecule
aggregate
levels
promote
outcomes.
Molecular
nanoengineering
modulate
processes
convert
absorbed
photons
into
fluorescent/phosphorescent/photoacoustic
signals
and/or
photodynamic/photothermal
curing
effects
improved
phototheranostics
are
elaborated.
Noteworthily,
adaptive
activatable
transformable
functions
demand,
regulation
such
as
chemiexcitation
efficacies
also
included.
A
brief
summary
discussion
current
challenges
future
perspectives
this
field
is
further
presented.
Nature Communications,
Journal Year:
2018,
Volume and Issue:
9(1)
Published: Aug. 14, 2018
Reactive
oxygen
species
(ROS)-induced
apoptosis
is
a
promising
treatment
strategy
for
malignant
neoplasms.
However,
current
systems
are
highly
dependent
on
status
and/or
external
stimuli
to
generate
ROS,
which
greatly
limit
their
therapeutic
efficacy
particularly
in
hypoxic
tumors.
Herein,
we
develop
biomimetic
nanoflower
based
self-assembly
of
nanozymes
that
can
catalyze
cascade
intracellular
biochemical
reactions
produce
ROS
both
normoxic
and
conditions
without
any
stimuli.
In
our
formulation,
PtCo
nanoparticles
firstly
synthesized
used
direct
the
growth
MnO2.
By
adjusting
ratio
reactants,
highly-ordered
MnO2@PtCo
nanoflowers
with
excellent
catalytic
efficiency
obtained,
where
behaves
as
oxidase
mimic
MnO2
functions
catalase
mimic.
this
way,
well-defined
not
only
relieve
condition
but
also
induce
cell
significantly
through
ROS-mediated
mechanism,
thereby
resulting
remarkable
specific
inhibition
tumor
growth.
Journal of the American Chemical Society,
Journal Year:
2018,
Volume and Issue:
140(44), P. 14851 - 14859
Published: Oct. 17, 2018
Hypoxia,
a
quite
universal
feature
in
most
solid
tumors,
has
been
considered
as
the
"Achilles'
heel"
of
traditional
photodynamic
therapy
(PDT)
and
substantially
impairs
overall
therapeutic
efficacy.
Herein,
we
develop
near-infrared
(NIR)
light-triggered
molecular
superoxide
radical
(O2-•)
generator
(ENBS-B)
to
surmount
this
intractable
issue,
also
reveal
its
detailed
O2-•
action
mechanism
underlying
antihypoxia
effects,
confirm
application
for
vivo
targeted
hypoxic
tumor
ablation.
Photomediated
generation
study
shows
that,
even
under
severe
environment
(2%
O2),
ENBS-B
can
generate
considerable
through
type
I
photoreactions,
partial
is
transformed
high
toxic
OH·
SOD-mediated
cascade
reactions.
These
radicals
synergistically
damage
intracellular
lysosomes,
which
subsequently
trigger
cancer
cell
apoptosis,
presenting
robust
PDT
potency.
In
vitro
coculture
model
benefiting
from
biotin
ligand,
achieves
87-fold
higher
cellular
uptake
cells
than
normal
cells,
offering
opportunities
personalized
medicine.
Following
intravenous
administration,
able
specifically
target
neoplastic
tissues
completely
suppresses
growth
at
low
light-dose
irradiation.
As
such,
postulated
work
will
extend
options
excellent
agents
clinical
therapy.
Advanced Materials,
Journal Year:
2019,
Volume and Issue:
31(39)
Published: July 22, 2019
Abstract
Catalysis
and
medicine
are
often
considered
as
two
independent
research
fields
with
their
own
respective
scientific
phenomena.
Promoted
by
recent
advances
in
nanochemistry,
large
numbers
of
nanocatalysts,
such
nanozymes,
photocatalysts,
electrocatalysts,
have
been
applied
vivo
to
initiate
catalytic
reactions
modulate
biological
microenvironments
for
generating
therapeutic
effects.
The
rapid
growth
biomedical
applications
nanocatalysts
has
led
the
concept
“nanocatalytic
medicine,”
which
is
expected
promote
further
advance
a
subdiscipline
nanomedicine.
high
efficiency
selectivity
catalysis
that
chemists
strived
achieve
past
century
can
be
ingeniously
translated
into
efficacy
mitigated
side
effects
theranostics
using
medicine”
steer
optimized
outcomes.
Here,
rationale
behind
construction
nanocatalytic
eludicated
based
on
essential
reaction
factors
(catalysts,
energy
input,
reactant).
Recent
this
burgeoning
field
then
comprehensively
presented
mechanisms
nanosystems
conferred
theranostic
functions
discussed
detail.
It
believed
an
emerging
modality
will
play
more
important
role
Advanced Materials,
Journal Year:
2019,
Volume and Issue:
31(21)
Published: March 25, 2019
Abstract
Over
the
past
3
years,
glucose
oxidase
(GOx)
has
aroused
great
research
interest
in
context
of
cancer
treatment
due
to
its
inherent
biocompatibility
and
biodegradability,
unique
catalytic
properties
against
β‐
d
‐glucose.
GOx
can
effectively
catalyze
oxidation
into
gluconic
acid
hydrogen
peroxide.
This
process
depletes
oxygen
levels,
resulting
elevated
acidity,
hypoxia,
oxidative
stress
tumor
microenvironment.
All
these
changes
be
readily
harnessed
develop
a
multimodal
synergistic
therapy
by
combining
with
other
therapeutic
approaches.
Herein,
representative
studies
GOx‐instructed
are
introduced,
their
mechanisms
discussed
systematically.
The
current
challenges
future
prospects
advance
development
GOx‐based
nanomedicines
this
cutting‐edge
area
highlighted.
Theranostics,
Journal Year:
2020,
Volume and Issue:
10(10), P. 4557 - 4588
Published: Jan. 1, 2020
In
recent
years,
much
progress
has
been
motivated
in
stimuli-responsive
nanocarriers,
which
could
response
to
the
intrinsic
physicochemical
and
pathological
factors
diseased
regions
increase
specificity
of
drug
delivery.
Currently,
numerous
nanocarriers
have
engineered
with
changes
responding
external
stimuli,
such
as
ultrasound,
thermal,
light
magnetic
field,
well
internal
including
pH,
redox
potential,
hypoxia
enzyme,
etc.
Nanocarriers
respond
stimuli
tumor
microenvironments
or
inside
cancer
cells
for
on-demanded
delivery
accumulation,
controlled
release,
activation
bioactive
compounds,
probes
targeting
ligands,
size,
charge
conformation
conversion,
etc.,
leading
sensing
signaling,
overcoming
multidrug
resistance,
accurate
diagnosis
precision
therapy.
This
review
summarized
general
strategies
developing
advances,
presented
their
applications
delivery,
imaging,
therapy
theranostics,
illustrated
clinical
translation
made
prospects.